Skip to main content
Novartis Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English
Novartis Foundation | English
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Board of Directors 
        • Giovanni Caforio 
        • Simon Moroney 
        • Nancy C. Andrews 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Bridgette Heller 
        • Frans van Houten 
        • Elizabeth McNally 
        • Ana de Pro Gonzalo 
        • Charles Swanton 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 
        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Patrick Horber 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Lutz Hegemann 
        • Teresa Jose 
        • Michelle Weese 
      • Products 
      • Therapeutic areas 
        • Cardiovascular, renal and metabolic 
        • Immunology 
        • Neuroscience 
        • Oncology 
      • People and culture 
      • Inclusion 
        • Promoting inclusion 
        • Building belonging 
        • Parental leave 
        • Caring for the mental health and wellbeing of our people 
      • Novartis Gene Therapies 
      • Manufacturing 
      • Quality 
        • Novartis quality management system (QMS) 
        • Audit program and regulatory inspections 
        • Product and patient safety training 
        • Product recalls 
        • Third-party suppliers 
      • Novartis and the European Union (EU) 
      • Awards and recognition 
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 296 million people worldwide.

    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Diseases 
      • Patient organization funding 
      • Patients perspectives stories 
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals 
      • Medical congresses and events 
        • ASCO Annual Meeting 
          • ASCO 2023 
      • Products 
      • Novartis pipeline 
      • Managed Access Programs 
        • Zolgensma® Global Managed Access Program (gMAP) 
      • Novartis external funding 
      • Healthcare professional resources by country 
      • Investigator-initiated trials / studies 
      • Novartis medical information 
        • Submit medical enquiry 
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development 
      • Technology platforms 
      • Research disease areas 
        • Cardiovascular and metabolic disease research at Novartis 
        • Diseases of Aging and Regenerative medicine (DARe) 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
      • Novartis pipeline 
      • Research collaborations 
      • Collaborations 
      Close up on the hands of a laboratory technician wearing blue gloves preparing a sample with pipette

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 
      • Access 
        • Creating sustainable business models 
        • Value-based pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis access principles 
        • Novartis oncology access 
        • Patents and licensing 
      • Environmental sustainability 
        • Nature 
        • Climate 
      • Ethics, risk and compliance 
        • Ethical behavior 
        • Compliance 
        • Human rights 
        • Learning and engagement 
        • Integrated risk assurance 
      • Global health 
        • Pandemic preparedness 
        • Avoidable blindness 
        • Chagas disease 
        • Leprosy 
        • Malaria 
        • Sickle cell disease (SCD) 
        • Novartis Foundation 
      • Inclusion 
      • ESG index 
      • Reporting and transparency hub 
        • ESG rating performance 
        • Patient organization funding 
        • Payments to healthcare professionals 
        • Public policy 
        • Animal research 
      HCP wearing a medical coat pulling a cart bicycle in rural african village

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 
      • Event calendar 
      • Financial data 
        • Novartis annual results 
        • Novartis quarterly results 
        • Novartis SEC filings 
        • Product sales 
        • Fixed-income securities 
        • Expected currency impact 
      • Share data and analysis 
        • Share monitor 
        • Dividend information 
        • Share ownership 
        • Share overview 
        • Return on investment calculator 
      • Shareholder information 
        • General Meetings 
        • American Depositary Receipts (ADR) 
        • Share buyback 
        • Frequently asked questions 
      • Company overview 
        • Corporate governance 
      • Reporting and transparency hub 
        • Reporting archive 
        • ESG rating performance 
        • Publications order form 
      • ESG 
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 
      • Newsroom 
      • Media library  
      • Stories 
      • Subscribe 
      • Events 
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including press releases, statements, stories, multimedia resources and more.

    • Careers 
      • Career search 
      • Our business functions 
        • Careers in research and development 
        • Careers in operations 
        • Careers in commercial and sales 
        • Careers in global functions 
      • Why Novartis 
      • Career hub 
        • Temporary contracts 
      • Early careers 
        • Graduates 
        • Students 
        • US Biomedical Research internship programs 
        • Community exploration and learning lab (CELL) 
      Three business people in a modern and bright meeting room

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials 
    • Partnering 
    • Supplier portal 
    • Report side effects 
    • Contacts 
    Mother and son cuddling on a couch in front of a window

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

Supplier onboarding region Asia Pacific Tab

Novartis Third Party Code Australia (English) (PDF 0.5 MB)

Novartis Terms and Conditions Australia (PDF 0.1 MB)

Supplier Onboarding Package Australia (PDF 1.3 MB) 

Novartis Third Party Code Azerbaijan (English) (PDF 0.5 MB)

Novartis Terms and Conditions Azerbaijan (English) (PDF 0.5 MB)

Supplier Onboarding Package Azerbaijan (PDF 2.6 MB)

Novartis Third Party Code Bangladesh (English) (PDF 0.5 MB)

Novartis Terms and Conditions Bangladesh (PDF 0.1 MB)

Novartis Third Party Code China (English) (PDF 0.5 MB)

Novartis Third Party Code Chinese (PDF 1.1 MB)

Invoice Instructions - China (PDF 0.3 MB)

Invoice Instructions - China HK (PDF 0.3 MB)

Purchase Order Terms and Conditions - China (PDF 2.9 MB)

Purchase Order Terms and Conditions - China HK (PDF 0.1 MB)

Novartis Third Party Code India (English) (PDF 0.5 MB)

Novartis Terms and Conditions India (PDF 0.2 MB)

Invoice Submission Guidelines (PDF 0.2 MB)

Novartis Third Party Code Indonesia (English) (PDF 0.5 MB)

Novartis Third Party Code Indonesia (Indonesian) (PDF 0.4 MB)

Novartis Terms and Conditions Indonesia (PDF 0.1 MB)

Supplier Onboarding Package Indonesia (PDF 1.2 MB)

Novartis Third Party Code Japan (English) (PDF 0.5 MB)

Novartis Third Party Code Japanese (PDF 0.8 MB)

Novartis Terms and Conditions Japan (PDF 0.7 MB), 約款 (PDF 0.2 MB)

Novartis Third Party Code (PDF 0.4 MB), ノバルティス 第三者規約(サプライヤー規約 (PDF 0.5 MB)

Novartis Invoice Guideline (PDF 2.0 MB), ノバルティス請求書発行ガイドライン (PDF 2.0 MB)

Supplier Onboarding Package Japan (PDF 2.2 MB)

Novartis Third Party Code Kazakhstan (English) (PDF 0.5 MB)

Novartis Terms and Conditions Kazakhstan (English) (PDF 0.5 MB)

Novartis Terms and Conditions Kazakhstan NTLE (English) (PDF 0.3 MB)

Supplier Onboarding Package Kazakhstan (PDF 2.6 MB)

Novartis Third Party Code Korea (English) (PDF 0.5 MB)

Novartis Third Party Code Korean (PDF 0.7 MB)

Novartis Terms and Conditions Korea (PDF 0.1 MB)

Novartis Third Party Code Malaysia (English) (PDF 0.5 MB)

Novartis Terms and Conditions Malaysia (PDF 0.1 MB)

Supplier Onboarding Package Malaysia (PDF 1.4 MB)

Novartis Third Party Code New Zealand (English) (PDF 0.5 MB)

Novartis Terms and Conditions New Zealand (PDF 0.1 MB)

Supplier Onboarding Package New Zealand (PDF 1.4 MB)

Novartis Third Party Code Pakistan (English) (PDF 0.5 MB)

Novartis Terms and Conditions Pakistan (PDF 0.1 MB)

Supplier Onboarding Package Pakistan (PDF 1.2 MB)

Novartis Third Party Code Philipines (English) (PDF 0.5 MB)

Novartis Terms and Conditions Philippines (PDF 0.1 MB)

Supplier Onboarding Package Philippines (PDF 1.2 MB)

Novartis Third Party Code Russia (English) (PDF 0.5 MB)

Novartis Third Party Code Russia (Russian) (PDF 0.6 MB)

Novartis Terms and Conditions Russia (PDF 0.1 MB)

Novartis Third Party Code Singapore (English) (PDF 0.5 MB)

Novartis Asia Pacific Pharmaceuticals Pte Terms and Conditions Singapore (PDF 0.1 MB)

Novartis Singapore Pharmaceuticals Manufacturing Terms and Conditions Singapore (PDF 0.1 MB)

Novartis (Singapore)Pte Ltd Terms and Conditions Singapore (PDF 0.1 MB)

Supplier Onboarding Package Singapore (PDF 1.4 MB)

Novartis Third Party Code Taiwan (English) (PDF 0.5 MB)

Novartis Terms and Conditions Taiwan (English) (PDF 0.2 MB)

Novartis Terms and Conditions Taiwan (PDF 0.6 MB)

Supplier Onboarding Package Taiwan (PDF 1.2 MB)

Novartis Third Party Code Thailand (English) (PDF 0.5 MB)

Novartis Terms and Conditions Thailand (PDF 0.1 MB)

Supplier Onboarding Package Thailand (PDF 3.2 MB)

Novartis Third Party Code Uzbekistan (English) (PDF 0.5 MB)

Novartis Terms and Conditions Uzbekistan (English) (PDF 0.5 MB)

Supplier Onboarding Package Uzbekistan (PDF 2.6 MB)

Novartis Third Party Code Vietnam (English) (PDF 0.5 MB)

Novartis Third Party Code Vietnam (Vietnamese) (PDF 0.6 MB)

Novartis Terms and Conditions Vietnam (PDF 0.2 MB)

Supplier Onboarding Package Vietnam (PDF 1.5 MB)

  • Print
  • PDF

Novartis

Working together
  • Patients and caregivers
  • Healthcare professionals
  • Researchers
  • Job seekers
  • Journalists
  • Investors
Topics
  • Access
  • ESG
  • SpeakUp
Explore
  • Pipeline
  • Products
  • Clinical trials
  • Partnering
  • Events
Therapeutic areas
  • Cardiovascular, renal and metabolic
  • Immunology
  • Neuroscience
  • Oncology
Footer Bottom
© 2026 Novartis AG
  • Terms of use
  • Privacy
  • Cookie settings
  • Contacts
  • Locations
  • Site map
  • Open source
  • Web accessibility
Novartis Site Directory
This site is intended for a global audience